Approaching Clinical Trials Where the Air Hurts Your Face
With the rise of cellular therapies and individualized medicine, cold chain study management has become a common issue in the…
Latest Cold Chain
-
2 years
-
2 years
-
2 years
-
2 years
-
2 years
-
2 years
-
2 years
-
2 years
Industry Viewpoints: How to Optimize Direct-to-Patient Shipping
Direct-to-patient clinical trials present better opportunities to retain patients and in effect enable more patient-centric studies. However, the challenges are…
Latest News
View More
Annex 16 and Achieving QP Release for EU Clinical Trials: Adapting Operationally to Meet the Latest Requirements
The EU-GMP Guide Annex 16 “Certification by a Qualified Person and Batch Release” debuted on April 15, 2016. The Annex credits the certification of a…
The Top 5: August 2018
There were numerous articles in August 2018 that covered a wide range of topical issues. Here are five of the best stories you might have…
Industry Viewpoints: Finding the Right Packaging Solution
In 2016, Logistics4Pharma was founded by industry experts working for different pharmaceutical logistic providers. Their aim was to meet the…
Logistical Considerations for the Central Asia Region: Challenges in the Multimodal Supply Chain of Thermolabile Products
In recent years, the number of medicines delivered and kept in special storage conditions have been on the rise. Most…
Active Cooling in Clinical Trial Logistics: Enabling Safe and Cost-Efficient Home-Based Clinical Trials
Home-Based Clinical Trials (HBCT) are the future of clinical trials. According to the CEO of Marken, Whes Wheeler, at least…
Announcing ‘Cold Chain Week’ on Clinical Trials Arena
This week, Clinical Trials Arena will be shining a spotlight on cold chain logistics as part of December’s ‘Cold Chain…
Latest Content
View More
How to Leverage Direct-to-Patient Shipping
In any industry, we are witnessing a common trend: The ever-growing attention given to customers and consumers. In this case,…
Temperature Monitoring in Clinical Trials in a Risk-Based Regulatory Landscape
As technology and materials have improved our ability to measure, monitor and maintain controlled temperatures in clinical trials, regulators are…
GEMTESA (vibegron) for the Treatment of Overactive Bladder (OAB)
GEMTESA® (vibegron) is the first new oral medication indicated for the treatment of overactive bladder (OAB) with signs of urge…
OpenClinica Featured in ‘In Depth’ Educational TV Series
OpenClinica is pleased to announce that it will be included in public television series In Depth, exhibiting its clinical trials…
ORGOVYX (relugolix) for the Treatment of Advanced Prostate Cancer
ORGOVYX™ (relugolix) is the first and only oral gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for the treatment of advanced prostate…
EVERSANA and Experic Partner for Life Sciences Industry Manufacturing and Commercialisation
EVERSANA™ and Experic are pleased to announce that they will be partnering to aid life sciences companies in optimising clinical…